|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Maxwell J. Mehlman (Arthur E. Petersilge Professor of Law, Case Western Reserve University)Publisher: Johns Hopkins University Press Imprint: Johns Hopkins University Press Dimensions: Width: 15.20cm , Height: 2.60cm , Length: 22.90cm Weight: 0.658kg ISBN: 9780801892639ISBN 10: 0801892635 Pages: 320 Publication Date: 09 September 2009 Recommended Age: From 18 years Audience: General/trade , General Format: Hardback Publisher's Status: Active Availability: Manufactured on demand We will order this item for you from a manufactured on demand supplier. Table of ContentsIntroduction 1. The Technological Horizon 2. Self-Satisfaction 3. Social Reward 4. The Hegemony of Meritocracy 5. Access to Enhancements and the Challenge to Equality 6. Lack of Choice 7. Enhancements in Sports 8. The Lessons from Sports 9. The War on Enhancements 10. Promoting Safety, Efficacy, and Informed Decisionmaking 11. Protecting the Vulnerable 12. Access and Inequality 13. Abominations 14. Research on Enhancement Conclusion Notes IndexReviewsIn his highly readable and especially timely new book, The Price of Perfection, Mehlman makes it clear that he is not at all persuaded that the ethical response to the availability of performance-enhancing drugs in sports-or elsewhere in society, for that matter-is to ban them and then spend a lot of effort testing for those who use them anyway. -- Arthur Caplan Perspectives in Biology and Medicine 2009 Bioethicists, as well as policy makers and the public, must think more often and more deeply about science's rapidly growing ability to improve human functioning. But what is present in The Price of Perfection, and sufficiently inspiring, is a well-balanced and well-documented look at how we now are positioned (at least in the United States) to control this process, and what some of the pros and cons of enlarging control, or alternatively loosening it, might be -- Anita Silvers International Journal of Feminist Approaches to Bioethics 2011 In his highly readable and especially timely new book, The Price of Perfection, Mehlman makes it clear that he is not at all persuaded that the ethical response to the availability of performance-enhancing drugs in sports-or elsewhere in society, for that matter-is to ban them and then spend a lot of effort testing for those who use them anyway. -- Arthur Caplan * Perspectives in Biology and Medicine * Bioethicists, as well as policy makers and the public, must think more often and more deeply about science's rapidly growing ability to improve human functioning. But what is present in The Price of Perfection, and sufficiently inspiring, is a well-balanced and well-documented look at how we now are positioned (at least in the United States) to control this process, and what some of the pros and cons of enlarging control, or alternatively loosening it, might be. -- Anita Silvers * International Journal of Feminist Approaches to Bioethics * In his highly readable and especially timely new book, The Price of Perfection, Mehlman makes it clear that he is not at all persuaded that the ethical response to the availability of performance-enhancing drugs in sports-or elsewhere in society, for that matter-is to ban them and then spend a lot of effort testing for those who use them anyway. -- Arthur Caplan Perspectives in Biology and Medicine 2009 Bioethicists, as well as policy makers and the public, must think more often and more deeply about science's rapidly growing ability to improve human functioning. But what is present in The Price of Perfection, and sufficiently inspiring, is a well-balanced and well-documented look at how we now are positioned (at least in the United States) to control this process, and what some of the pros and cons of enlarging control, or alternatively loosening it, might be. -- Anita Silvers International Journal of Feminist Approaches to Bioethics 2011 Author InformationMaxwell J. Mehlman is the Petersilge Professor of Law and director of the Law-Medicine Center in the School of Law, Case Western Reserve University, where he is also a professor of bioethics in the School of Medicine and the associate director for public policy in the Center for Genetics Research, Ethics, and Law. He is the author, coauthor, or coeditor of several books on medical ethics and genetics, including Wondergenes; The Encyclopedia of Ethical, Legal, and Policy Issues in Biotechnology; and Access to the Genome. Tab Content 6Author Website:Countries AvailableAll regions |
||||